Medipost‌‍‍‌‍‌‍‍‌‍‍‍‍‌‍‍‍

Biotech firm jointly acquired by Crescendo and Skylake

Tracked Biotech firm jointly acquired by Crescendo and Skylake · 1 documented connection

Facts on record6

Connections mapped1

Sources cited6

View on Graph → Export CSV ← Entity Directory

Stated vs Revealed

No documented contradictions on file.

PATTERN company → [investment] → company → [investor] → company 10× PATTERN company → [investor] → company → [investment] → company 10× PATTERN company → [investment] → company → [portfolio company inv... 3× PATTERN company → [investment] → company → [founder] → person 3× PATTERN person → [founder] → company → [investment] → company 3×

Connection Map

Key Connections

← Entity #18

investment

Most recent investment made on January 9, 2026

Facts (6)

Data Freshness

Fresh Last update: 15d ago · Avg age: 127d

Confidence Tiers: Primary Source — cross-referenced government/corporate filings Pending Review — sourced but not independently verified AI Inference — analytical hypothesis from cross-referencing

Raw Filing Records (1) — unsourced metadata

Pending Review Medipost filed filing with the SEC o‌‍‍‌‍‌‍‍‌‍‍‍‍‌‍‍‍n 2024-03-11. Accession number: N/A.

Date: 2024-03-11 Added: 12 Apr 2026

All Connections (1)

← Entity #18

investment confirmed

Most recent investment made on January 9, 2026

Sources (6)

2026 UNVERIFIED Research: Medipost — Parliamentary records (no results) parliamentary_record Processed

2026 UNVERIFIED Research: Medipost — Court records (no results) court_document Processed

2026 UNVERIFIED Research: Medipost — Lobbying disclosures (no results) government_disclosure Processed

2026 UNVERIFIED Research: Medipost — Corporate registrations (no results) government_disclosure Processed

2026 UNVERIFIED Research: Medipost — USASpending contracts (no results) contract Processed

2024-03-11 ↗ SEC EDGAR: filing — Medipost (2024-03-11) web_search Processed